[1]
“A Review: Association of Alpha-fetoprotein With Metabolic Syndrome”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 736–748, Oct. 2022, doi: 10.47750/pnr.2022.13.04.099.